BenevolentAI
powerful data foundations generate a view of disease biology experiments assay data binding comparison screens clinical trial genes proteins transcripts variants biological systems cellular component molecular function biological process mechanism pathways literature literature patent literature regulatory documents diseases symptoms molecules organic compounds preclinical candidates approved drugs antibodies other pharmacology multimodal approach combines over data sources to provide a holistic view of disease biology our probability of clinical success by integrating disease traits genetics and data to generate target predictions breaks down silos across therapeutic areas to connect shared mechanisms across disease provides a proprietary integrated view of data that supports discovery and decision making | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
6 of 38
Similar slides by BenevolentAI
See diffirences between slides (animation)
Investor Conference
January 2023
generating a view of disease biology multimodal approach combines over data sources to provide a holistic view of disease biology our probability of clinical success by integrating disease traits genetics and data to generate target predictions breaks down silos across therapeutic areas to connect shared mechanisms across disease provides a proprietary integrated view of data that supports discovery and decision making | BenevolentAI
Related slides by other companies
Sema4
SPAC
August 2021
our health data engine | Sema4
Recursion Pharmaceuticals
Investor Day
January 2023
literature drives discovery informs target based hypotheses data are an exhaust limited to testing hypotheses disparate data generation to individual programs and diseases linear process little cross program learning or iteration bespoke processes low dimensional assays platforms drive discovery unbiased target agnostic data are our fuel shape our hypotheses connected data across programs relatable high dimensional data virtuous cycles of atoms bits iterative feedback accelerates learning industrialized to scale standardization recursion map based approach is designed set the standard for drug in the century | Recursion Pharmaceuticals
Absci
Investor Presentation
October 2022
is merging synthetic biology to accelerate biologic drug creation | Absci
NVIDIA
Investor Presentation
February 2024
factories a new class of data centers | NVIDIA
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Investor Conference
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io